
Novo Nordisk Forges Multiple Partnerships To Sell Obesity Drug Wegovy At A Discount
The pharmaceutical firm Novo Nordisk is pursuing a multi-pronged strategy to regain market share ... More that it has lost to Eli Lilly in the lucrative obesity drug market. One of its weight loss products, Wegovy (semaglutide), is an injectable …